A 58-year-old man with a 10-year history of atrial fibrillation presents with acute left lower limb ischemia. Angiography confirms thrombotic occlusion of the femoral artery. After mechanical thrombectomy, what is the drug of choice for preventing recurrent thromboembolism in this patient?

Explanation

## Anticoagulation in Atrial Fibrillation with Arterial Thromboembolism ### Clinical Context This patient has atrial fibrillation complicated by acute arterial thromboembolism (acute limb ischemia). After successful mechanical revascularization, long-term anticoagulation is essential to prevent recurrence. ### Drug of Choice: Warfarin (or DOAC) **Key Point:** Warfarin is the gold standard anticoagulant for preventing thromboembolic complications in atrial fibrillation. DOACs (dabigatran, rivaroxaban, apixaban, edoxaban) are equally effective alternatives and increasingly preferred. **High-Yield:** Anticoagulation (not antiplatelet therapy) is indicated for: - Atrial fibrillation with CHA₂DS₂-VASc score ≥ 1 in men, ≥ 2 in women - Secondary prevention after arterial thromboembolism - Target INR for AF: 2–3 [cite:Harrison 21e Ch 297] ### Why Warfarin Over Alternatives? | Feature | Warfarin | Aspirin | Clopidogrel | Fondaparinux | |---------|----------|---------|------------|---------------| | **Mechanism** | Vitamin K antagonist (Factor II, VII, IX, X) | COX inhibitor | P2Y₁₂ antagonist | Factor Xa inhibitor | | **Efficacy in AF** | Reduces stroke by 60–70% | Minimal benefit (~20%) | Not indicated for AF | Not for long-term AF | | **Route** | Oral | Oral | Oral | Subcutaneous | | **Use in AF** | First-line | Not recommended | Not recommended | Acute VTE/ACS only | **Clinical Pearl:** Aspirin and clopidogrel are antiplatelet agents; they are ineffective for preventing cardioembolic stroke in atrial fibrillation. Anticoagulation is mandatory. ### Timing of Anticoagulation After acute arterial thromboembolism and mechanical revascularization, anticoagulation should be initiated urgently (within 24–48 hours if no contraindications) to prevent recurrent thrombosis. **Tip:** Remember the distinction: - **Anticoagulants** (warfarin, DOACs, heparin) → for cardioembolic/venous thrombosis - **Antiplatelets** (aspirin, clopidogrel) → for atherosclerotic arterial disease In this case, the thrombus originates from AF (a cardiac source), so anticoagulation is superior.